EH
Therapeutic Areas
BioArctic AB Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lecanemab (Leqembi®) | Early Alzheimer's Disease | Approved |
| BAN2802 | Alzheimer's Disease | Preclinical |
| BAN2401 | Parkinson's Disease | Phase 1 |
| BAN0805 | Parkinson's Disease | Preclinical |
| Anti-alpha-synuclein Oligomer mAb | Multiple System Atrophy (MSA) | Discovery |
| Undisclosed Program | ALS | Discovery |